Eagle IP attended the Hong Kong MedTech Innovation World Cup, a major international event showcasing cutting-edge medical technology innovations, startups, and industry leaders in March 2025.

Our Principals Ms. Jennifer Che and Ms. Yolanda Wang served as judges at a multiday pitch competition that will be occurring during the event. As a leading intellectual property firm in Hong Kong, Eagle IP is participating to engage with MedTech innovators, investors, and industry professionals. The event provides an excellent platform for the team to connect with companies developing novel medical devices, diagnostics, digital health solutions, and other healthcare technologies, while offering expert insights on IP protection and commercialization strategies in Asia.

我们的过去活动

Recommended Insights

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

2025年3月10日
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]

China Releases Draft Examination Guidelines for the new Patent Law

2020年12月4日
The Chinese Patent Office (CNIPA) is moving forward at breakneck speeds aiming to get all the necessary pieces in place for the June 1, 2021 date when the new 4th Amendment of the Patent Law will come into effect. Most recently, this means a flurry of drafts coming out from CNIPA, including, but not limited […]

Breaking News: China passes Fourth Amendment to the Chinese Patent Law

2020年10月19日
After 12 years, the Fourth Amendment to the Chinese Patent Law has passed and will be in effect on 1 Jun 2021. After years of multiple draft amendments that moved in various directions, we FINALLY have some clarity on what patent protection is going to look like in China in the coming future. Many of […]

IP Strategies for the Newly Released Implementation Regulations of the 4th Amendment of the Chinese Patent Law: Part 1: Delayed Examination

2024年1月25日
December 2023 appears to have been an exceptionally busy and fruitful month in the China patent space. Following the State Council’s approval of the long-awaited Patent Law Implementation Regulations (“Regulations”, similar to the CFR in the US) in November, the CNIPA finally made public the full text of the Regulations just before the arrival of […]
Top crossarrow-right